Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy.
Ravaud A, Motzer RJ, Pandha HS, George DJ, Pantuck AJ, Patel A, Chang YH, Escudier B, Donskov F, Magheli A, Carteni G, Laguerre B, Tomczak P, Breza J, Gerletti P, Lechuga M, Lin X, Martini JF, Ramaswamy K, Casey M, Staehler M, Patard JJ; S-TRAC Investigators. Ravaud A, et al. N Engl J Med. 2016 Dec 8;375(23):2246-2254. doi: 10.1056/NEJMoa1611406. Epub 2016 Oct 9. N Engl J Med. 2016. PMID: 27718781 Free article. Clinical Trial.
Patient's and physician's behavior on the management of benign prostatic hyperplasia among the patients at the risk of clinical progression. A multicenter noninterventional trial in Slovakia by "Prostate and Expectations of Treatment: Epidemiology Research" (PETER) study group.
Weibl P, Laurinc P, Tomaškin R, Klatte T, Shariat F S, Helbich M, Fačkovcova D, Bujdák P. Weibl P, et al. Among authors: laurinc p. Wien Klin Wochenschr. 2015 Jun;127(11-12):434-9. doi: 10.1007/s00508-015-0751-5. Epub 2015 Mar 28. Wien Klin Wochenschr. 2015. PMID: 25821056
Patient's behavior and attitudes toward the management of benign prostatic hyperplasia among patients with the risk of disease progression: prospective study by "Prostate and Expectations of Treatment Epidemiology Research (PETER) study group".
Weibl P, Klatte T, Laurinc P, Tomaškin R, Shariat SF, Helbich M, Fackovcova D, Bujdák P. Weibl P, et al. Among authors: laurinc p. Wien Klin Wochenschr. 2015 May;127(9-10):363-8. doi: 10.1007/s00508-014-0668-4. Epub 2014 Dec 2. Wien Klin Wochenschr. 2015. PMID: 25447967